GALNT2 mRNA levels, as normalized for GAPDH expression, were progressively reduced from non-obese non-diabetic individuals, to obese non-diabetic individuals and to obese patients with type 2 diabetes (p for trend <0.001). This evidence concerns the gene GALNT2 and type 2 diabetes mellitus.